# Resbiotic Nutrition

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/resbiotic-nutrition

- Industry: Biotechnology
- Headquarters: Birmingham, US
- Website: www.resbiotic.com
- Total disclosed funding: $3M
- Latest round: Seed (Apr 29, 2021)
- Investors on record: 1

## About

Based in the Birmingham, US, Resbiotic Nutrition Inc. is a biotechnology company focused on developing scientifically-backed probiotic and prebiotic supplements that enhance lung, gut, and metabolic health for consumers seeking optimal wellness. Founded in 2021 and headquartered in Birmingham, US, ResBiotic, Inc. specializes in the formulation of health supplements. The company was established by C Lal, who has prior entrepreneurial experience. In September 2025, Resbiotic Nutrition Inc. raised USD 1 million in venture funding from unspecified investors. The round was part of a larger USD 2.5 million series A funding. ResBiotic specializes in developing scientifically-backed probiotic, prebiotic, and postbiotic supplements aimed at enhancing lung, gut, and metabolic health. Their core products include the resB® Lung Support Probiotic, the resM™ GLP-1 Postbiotic, and the Synbiotic Reset Bundle, each addressing specific health issues such as digestive health, weight management, and respiratory wellness. The company markets its products primarily to health-conscious consumers and healthcare providers, serving markets in North America, Europe, and select regions in Asia. ResBiotic generates revenue through direct-to-consumer sales, subscriptions, and partnerships with healthcare providers and wellness retailers. Customers can purchase products individually or through subscription services, which provide regular deliveries. The pricing strategies for products such as the resM™ GLP-1 Postbiotic and Synbiotic Reset Bundle are competitive, appealing to health-focused consumers and professionals. The company emphasizes ease of access and customer retention through subscriptions, underpinned by scientific validation and physician endorsement. The company will use the September 2025 funding to expand its product line, support clinical research, and grow its team.

## Funding rounds

- Seed, Apr 29, 2021, $3M — Timberline

## Investors

- Timberline (https://capitalatlas.ai/funds/timberline) — Seed